BioCanRx held a public forum as part of its Summit for Cancer Immunotherapy held in June 2017 in Gatineau, Quebec. It was called: Immunotherapy - A cancer treatment game-changer? The event provided members of the public with an opportunity to separate fact from fiction by hearing the latest advances in cancer immunotherapy research from experts developing ground-breaking therapeutics that harness the body's immune system to fight cancer. Expert panelists include Dr. John Bell, senior scientist at the Cancer Therapeutics Program, The Ottawa Hospital and BioCanRx Scientific Director, Dr. Harold Atkins, scientist at the Cancer Therapeutics Program and Attending Physician, Blood and Marrow Transplant Program, The Ottawa Hospital, and Dr. Marcus Butler, Clinical Head of the Immune Monitoring Team at The Princess Margaret Cancer Centre. You will also hear firsthand from Ramona Bietlot, a patient who has benefitted from immunotherapy. Linda Eagen, President & CEO of the Ottawa Regional Cancer Foundation, moderated the evening.